| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Circassia Group Plc |
LSE:CIR |
London |
Ordinary Share |
GB00BJVD3B28 |
ORD 0.08P |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
-1.00 |
-2.9% |
33.50 |
4,646,236 |
16:35:23 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
33.00
|
34.00
|
34.00 |
33.90 |
33.90 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Pharmaceuticals & Biotechnology
|
27.90
|
-2.10
|
1.00
|
33.5
|
140
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 16:33:46 |
O |
4,375,000 |
34.00 |
GBX |
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
| 2022-07-01 15:33:48 | 34.00 | 4,375,000 | 1,487,500.00 | O |
| Date | Subject |
|---|
02/7/2022
09:20 | Circassia Daily Update: Circassia Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker CIR. The last closing price for Circassia was 34.50p.
Circassia Group Plc has a 4 week average price of 29p and a 12 week average price of 29p.
The 1 year high share price is 48.55p while the 1 year low share price is currently 28.55p.
There are currently 419,317,012 shares in issue and the average daily traded volume is 355,608 shares. The market capitalisation of Circassia Group Plc is £140,471,199.02.
|
12/5/2022
08:33 | drdre: I have been watching CIR a while and impressed by recent newsflow. Whats the target addressable market they are in?
|
22/3/2022
07:23 | saadia110: Amazing results today, let's see the price action today.
|
10/3/2022
14:38 | thedudie: Price being driven back up today - Recent trading statement said results are on 22 March.
|
10/2/2022
16:28 | masurenguy: Took an opening position in CIR earlier today.
|
25/1/2022
19:41 | p1nkfish: What a lovely bit of closing action. £8M+ at what appears just over the ask price.
Something afoot?
41x average volume approx.
|
25/1/2022
16:52 | ayl30: Big trades and jump in price near the close, interesting!
|
13/1/2022
11:29 | apad: CIR is commented on in this morning's SCVR.
apad
|
12/1/2022
14:47 | masurenguy: Re post #1057 - CIR was tipped this morning.
|
24/12/2021
10:28 | someuwin: One way or another CIR should be a big winner in 2022.
|
21/4/2021
15:29 | 1pencil: On the topic of why would Astra Zeneca dispose of their holding. My reading of the situation is it formed part of the original partnership agreement back in 2017 (see below excerpt).
Therefore it seems reasonable to assume AZ will at some point unwind this position now the partnership has ended.
"Under the terms of the agreement, AstraZeneca will receive $50 million in Ordinary Shares in Circassia, calculated by reference to the lower of the weighted average share price of Circassia over the period 20 days (i) prior to signing or (ii) prior to closing (subject to a maximum number of shares). Circassia will also pay $100 million at the earlier of approval of Duaklir in the US or 30 June 2019. Should Circassia decide to exercise the option to sub-license the commercial rights to Tudorza in the US, Circassia will pay up to a further $80 million."
HTTPS://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-and-circassia-enter-strategic-collaboration-in-respiratory-disease-17032017.html#
|
Circassia share price data is direct from the London Stock Exchange
PLUS1
IN BRIEF: Circassia gets USD10.5 million after BeyondAir US FDA win